Clinical Trial Update: Fotemustine in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fotemustine for metastatic melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Fotemustine (fotemustine)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Melanoma (Skin) | Phase 2 | Status: TERMINATED